The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 29, 2024
Filed:
Mar. 10, 2023
Applicant:
Atai Therapeutics, Inc., New York, NY (US);
Inventors:
Srinivas G. Rao, Encinitas, CA (US);
Glen Short, Scituate, MA (US);
Majed Fawaz, Foxboro, MA (US);
Prerak Patel, Flemington, NJ (US);
Santnu Patel, Ruppur, IN;
Assignee:
ATAI Therapeutics, Inc., New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4045 (2006.01); A61K 9/00 (2006.01); A61K 9/70 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01); A61K 47/38 (2006.01); A61K 47/42 (2017.01);
U.S. Cl.
CPC ...
A61K 31/4045 (2013.01); A61K 9/006 (2013.01); A61K 9/7007 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); A61K 47/38 (2013.01); A61K 47/42 (2013.01);
Abstract
Pharmaceutical compositions including an amorphous N—N-dimethyltryptamine (DMT) or a pharmaceutically acceptable salt or prodrug thereof, and a polymeric carrier are described. These compositions are suitable for buccal or sublingual administration to a patient. Methods of treating disorders, including neurological disorders, by administration of these compositions are described.